Dr. Wen received his PhD in Biostatistics at The University of Texas Health Science Center in Houston (2009). He previously was a Principal Statistical Analyst at MD Anderson Cancer Center from 2001- 2012, and had served as a biostatistician on several NIH/NCI funded grants such as NCI Specialized Program of Research Excellence (SPORE) in prostate cancer and genitourinary cancer, respectively. Dr. Wen participates in the design and analysis of numerous clinical trials, laboratory experiments and observational studies. He has extensive skills with simulations for clinical trial designs. Much of his work has been computer-intensive and draws heavily on Markov Chain Monte Carlo (MCMC) algorithms for inference.